INNV- FlutiCare has been proven more effective than Flonase and INNV is expecting FDA approval any day now. Flonase sales are over $20 million a month and INNV market cap is only about 30 million so you can see the potential here.
(2)
(0)
Innovus Pharmaceuticals Inc. (INNV) Stock Research Links